Graham Capital Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-67,550	Closed	-$215K	–	1301
2025 Q1	$215K	Buy	67,550 +49,245	+269%	+$157K	﹤0.01%	1084
2024 Q4	$97.9K	Buy	+18,305	New	+$97.9K	﹤0.01%	1132